A first-choice combined oral contraceptive influences general well-being in healthy women: a double-blind, randomized, placebo-controlled trial

A randomized, placebo-controlled trial on a firstchoice combined oral contraceptive found decreased general well-being but no statistically significant effect on depressive symptoms in healthy women.
Published
Go to the profile of Fertility and Sterility
Fertility and Sterility
Editorial Office, American Society for Reproductive Medicine
A first-choice combined oral contraceptive influences general well-being in healthy women: a double-blind, randomized, placebo-controlled trial

Volume 107, Issue 5, Pages 1238–1245

Authors:

Niklas Zethraeus, Ph.D., Anna Dreber, Ph.D., Eva Ranehill, Ph.D., Liselott Blomberg, B.Sc., Fernand Labrie, M.D., Ph.D., Bo von Schoultz, M.D., Ph.D., Magnus Johannesson, Ph.D., Angelica Lindén Hirschberg, M.D., Ph.D.

Abstract:

This study demonstrates a statistically significant reduction in general well-being by a first-choice OC in comparison with placebo in healthy women. We found no statistically significant effects on depressive symptoms. A reduction in general well-being should be of clinical importance.


Read the full text here.

Go to the profile of Fertility and Sterility
Fertility and Sterility
Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. 

Recommended Content